论文部分内容阅读
肺动脉高压(pulmonary arterial hypertension,PAH)是一种严重威胁人类健康的难治性疾病。其手术治疗效果不佳。临床多以药物治疗为主,达到缓解症状、改善生活质量、预防疾病进展的目的。近年来,干细胞的研究为肺动脉高压的治疗提供了新的方向。研究证实其治疗效果可优于传统方法。随着研究的深入,干细胞治疗正越来越受到大家的关注。本文就干细胞治疗肺动脉高压应用的进展进行综述。
Pulmonary arterial hypertension (PAH) is a refractory disease that seriously threatens human health. The surgical treatment of poor results. Most clinical drug treatment, to relieve symptoms, improve quality of life, prevent disease progression. In recent years, stem cell research has provided a new direction for the treatment of pulmonary hypertension. Studies confirm that the treatment effect can be superior to the traditional method. With the deepening of research, stem cell therapy is receiving more and more attention. This article reviews the progress of stem cell therapy for pulmonary hypertension.